NT-proBNP/TP was elevated (3,475 vs. 518 ng/g, p=0.008), and ductus venosus pulsatility index (DV-PI) was high (1.34 vs. 0.75, p=0.020). Bilateral E/e' in recipients decreased 4-7 days after FLP (p=0.007). As for donor twins, no significant change was seen in bilateral E/e'. Conclusions: The measurement of fetal E/e' using DD method was convenient and stable. E/e' is seemed a useful parameter of fetal cardiac dysfunction in recipient twins, related with amniotic fluid NT-proBNP and DV-PI. Interestingly, bilateral E/e' of recipients indicated significant decrease within 7 days after FLP. These findings might imply FLP improves pathological condition of diastolic dysfunction in recipient twins.
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Assessment of fetal cardiac function and structure in monochorionic diamniotic twins with Twin-twin transfusion syndrome before and after fetal therapy Objectives: To evaluate fetal cardiac structure and function in monochorionic diamniotic (MCDA) twins with Twin-twin transfusion syndrome (TTTS) before and after fetal therapy. Methods: We conducted a prospective case-control study (January 2015 and December 2016) . 70 MCDA pregnancies with TTTS that underwent fetal surgery were included and compared with 140 uncomplicated MCDA fetuses adjusted by gestational age. Fetal cardiac morphometry and function were assessed by echocardiography using 2D imaging, M-mode and conventional Doppler at the diagnosis and 24-48hrs after surgery. Results were evaluated by multivariate regression analysis. Results: At the diagnosis, recipient fetuses showed larger hearts with thicker walls when compared with donors and controls (mean cardiothoracic ratio: 0,29; 0,22; 0,23 p<0,001; mean septal thickness: 2,86; 2,06; 2,46 p< 0,01). Recipient and donors showed systolic dysfunction when compared with controls (table  1) . Diastolic dysfunction is observed in recipients as increased isovolumetric relaxation time and higher E and A velocities (p<0.001). Cardiac function parameters improved after surgery in recipient and donors. However, when compared with controls, cardiac dysfunction persisted. Recipients cardiac remodelling remained stable after surgery. Objectives: To investigate the value of a new Jellyfish sign (JS) for predicting the risk of morbidly adherent placenta (MAP) in patients with placenta previa totalis. Methods: Retrospective study of singleton pregnancies with placenta previa totalis irrespective to previous CS or number of previous pregnancies were included in the study, evaluated by TA and TV ultrasound to assess the probability for MAP and definition of the surgical risk. The presence/severity of MAP were determined after pathological analysis or according to surgeons' report. Results: JS was found in 8 of 39 (20.5%) included patients. The 2 groups, with or without JS, were similar. The specificity of the JS in the diagnosis of MAP, the histological findings of accretism/incretism/percretism, the need of Caesarean hysterectomy or blood loss > 2,000 ml ranges between 92 and 96.2%, with the PPV and NPV ranging between 71.4 and 85.7% and 61.3 and 80.6%, respectively. JS group had a significant increase of total blood loss (ml) (p=0.003), transfusions (%) (p=0.016) of red blood cells (p=0.002) and plasma (p=0.002), admission to postoperative intensive care unit (%) (p=0.002), hospitalisation days (p<0.001) and Caesarean hysterectomy (%) (p<0.001). JS was independently correlated to Caesarean hysterectomy (OR 25.6; 95% CI 2.0:322.3, p=0.012) and blood loss > 2,000 ml (OR 16.6; 95% CI 1.5:180.1, p=0.021) in a logistic regression model. Conclusions: JS is useful in predicting the increase of maternal morbidity: massive transfusion, admission to ICU and Caesarean hysterectomy related to massive intraoperative bleeding in patients with previa totalis placenta.
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